Long-term safety and efficacy of aliskiren and valsartan combination with or without the addition of HCT in patients with hypertension.

Author: ChrysantSteven G, DattaniDan, HoppeUta C, MurrayAlexander V, PatelSamir, RitterShannon, ZhangJack

Paper Details 
Original Abstract of the Article :
OBJECTIVE: To assess the long-term safety and antihypertensive efficacy of aliskiren/valsartan 300/320 mg combination. METHODS: This was a 54-week, multicenter, open-label study (core phase), followed by a 26-week extension phase. Efficacy variables were change in msDBP and msSBP from baseline to e...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1185/03007995.2010.528282

データ提供:米国国立医学図書館(NLM)

Long-Term Safety and Efficacy of Aliskiren and Valsartan Combination with or without the Addition of HCT in Patients with Hypertension

In the world of [cardiology], managing [hypertension] is crucial for preventing cardiovascular disease. This study explores the long-term safety and efficacy of a combination of [aliskiren] and [valsartan] with or without [hydrochlorothiazide (HCT)] for treating [hypertension].

Aliskiren and Valsartan Combo May be Effective for Hypertension

This study found that the combination of [aliskiren] and [valsartan] was effective in reducing [blood pressure] and was generally well-tolerated. The addition of [HCT] further improved [blood pressure control] in patients who did not achieve adequate control with the combination alone.

Managing Hypertension

If you have [hypertension], it’s important to work closely with your doctor to manage your condition effectively. This study provides valuable information about potential treatment options, including the combination of [aliskiren] and [valsartan].

Dr.Camel's Conclusion

This research reminds us that the desert of [cardiology] is a landscape of ongoing exploration. We are constantly discovering new ways to manage [hypertension], and this study provides valuable insights for physicians and patients alike.
Date :
  1. Date Completed 2011-03-01
  2. Date Revised 2015-11-19
Further Info :

Pubmed ID

21062137

DOI: Digital Object Identifier

10.1185/03007995.2010.528282

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.